Skip to main content

Complications of Peptic Ulcer Disease!

 COMPLICATIONS OF PEPTIC ULCER DISEASE

  1. Bleeding peptic ulcer
  2. Pyloric stenosis
  3. Zollinger-Ellison Disease
  4. Stress Ulcers


Bleeding peptic ulcer:

  • Peptic ulcer is the most common cause of non-variceal upper gastro-intestinal bleeding.
  • Most patients with bleeding peptic ulcer are clinically stable and stop bleeding without any intervention, whereas other outcomes include re-bleeding and mortality.
  • Endoscopy allows identification of the severity of disease.
  • Endoscopic hemostatic therapy which is successful in reducing mortality.
  • A number of pharmacological agents have been used for endoscopic injection therapy such as 1:10000 adrenaline (epinephrine), human thrombin and fibrin glue.
  • Mechanical endoscopic treatment options include Thermocoagulation using a heater probe or endoscopic clipping.
  • Combination therapies are superior to monotherapy and a combination of adrenaline 1:10000 with either thermal or mechanical treatment is recommended (SIGN,2008).



Pyloric Stenosis:

Malignancy is the most common cause of gastric outlet obstruction.
Peptic ulcer disease is the underlying cause in about 10% of cases.
Conventional treatment with acid-suppressive therapy may also help.
If medical therapy fails to relieve the obstruction, Endoscopic balloon dilation or surgery may be required.


Zollinger-Ellison Syndrome:

  • This is a rare syndrome that consists of a triad of non-beta cell tumors of the pancreas that contain and release gastrin, gastric acid hypersecretion and severe ulcer disease.
  • Extra-pancreatic gastrinomas are also common and may be frequently found in the duodenal wall.
  • A proportion of these patients have tumors of the pituitary gland and parathyroid gland.
  • Patients with idiopathic peptic ulcer disease should be investigated for Zollimger-Ellison Syndrome.
  • Medical management includes; greater than standard doses of Proton Pump Inhibitors. The somatostatin analogue OCTREOTIDE is also effective but has no clear advantage over PPIs.


Stress Ulcers:

  • Sever physiological stress such as Head Injury, Spinal cord injury, Burns, Multiple traumas or Sepsis may induce superficial mucosa erosions or gastroduodenal ulcerations. These may lead to hemorrhage or perforation.
  • Diminished blood flow to the gastric mucosa, decreased cell renewal, diminished prostaglandin production and hypertension are involved in causing stress ulceration.
  • Management involves: Intravenous acid-suppression therapy, Histamine H-receptor antagonists, PPIs and Nasogastric tube administration of SUCRALFATE (4-6g daily in divided doses) have been used to prevent stress ulceration in the intensive care unit until patient tolerates enteral feeding.
Most commonly used regimens are: IV Ranitidine 50mg every 8hr reducing to 25mg in severe renal impairment.
  • Patients at Mechanical ventilation and the presence of coagulopathies are at higher risks of stress-related mucosal bleeding and may require prophylactic treatment.


Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-5...
Post a Comment
Read more

Diabetes Mellitus: Types!

TYPES OF DIABETES MELLITUS 1. TYPE1 DM Type 1 DM is usually diagnosed before age 30 years, but it can develop at any age. T1DM is an autoimmune disease in which insulin producing B-cells are destroyed. The presence of Human Leucocyte Antigens (HLAs ) is associated with the development of T1DM. In addition, these individuals often develop Islet cell antibodies , Insulin Autoantibodies or Glutamic Acid decarboxylase autoantibodies . At the time of development of diagnosis of T1DM, it is usually believed that most of the patients have 80-90%loss of beta cells. The remaining beta cells function at the diagnosis creates a " HONEYMOON PERIOD" during which the blood glucose levels are easier to control, and smaller amounts of insulin are required. after this, the remaining beta cells function is completely lost, and the patients become completely deficient of insulin and hence require exogenous insulin.  2. TYPE1.5 DM:  Also referred as Latent autoimmune diabetes in Adults (LAD) ...
Post a Comment
Read more

Diabetes Mellitus: Etiology and Epidemiology!

 DIABETES MELLITIS Definition: Diabetes Mellitus (DM) describes a group pf chronic metabolic  disorders characterized by hyperglycemia that may result in long-term microvascular, macrovascular and neuropathic complications. these complications contribute to diabetes being the leading cause of: a) new cases of blindness among adults b) end stage renal diseases c)non-traumatic lower limb amputations Etiology: The increasing prevalence is caused by three influences: 1. ethnicity        2. Lifestyle       3. Age Types: a) Type 1 DM b) Type 2 DM c) Type 1.5DM d) Gestational Diabetes Mellitus (GDM) ** In type 1 DM; the body fails to make insulin. In type 2 DM; body either develops resistance to insulin or not enough insulin is produced to lower the Blood glucose levels** Epidemiology The worldwide prevalence of DM has risen over past two decades with an estimation of 30 million cases in 1985 to 177 million cases in 2000. Based on current trend...
Post a Comment
Read more